Ramaswamy Govindan, MD

Ramaswamy Govindan, MD

Anheuser Busch Endowed Chair in Medical Oncology, Associate Chief of Oncology

Address:
Division of Oncology
Mail Stop 8056-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110

11th Floor Mid Campus Center (office)

Admin:
Kim Blasé
kblase@wustl.edu

Biosketch

Education

  • 1990: MD, University of Pondicherry, India
  • 1986: MBBS, University of Madras, India

Post-Graduate Training

  • 1996-1993: Fellow, Hematology/Oncology, Washington University, Department of Internal Medicine, St. Louis, MO
  • 1993-1991: Intern and Resident, Internal Medicine, Michael Reese Hospital and Medical Center, Chicago, IL
  • 1991-1990: Chief Resident, Jawaharlal Institute of Postgraduate Medical Education and Research, India
  • 1990-1987: Resident, Internal Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, India

Academic Positions & Employment

  • present-2022: Associate Chief, Division of Oncology, Department of Medicine, Washington University, St Louis, MO
  • present-2015: Director, Section of Medical Oncology, Division of Oncology, Department of Medicine, Washington University, St Louis, MO
  • present-2010: Professor, Department of Medicine, Washington University Medical School, St. Louis, MO
  • 2015-2010: Co-Director, Section of Medical Oncology, Division of Oncology, Department of Medicine, Washington University, St Louis, MO
  • 2009-2003: Associate Professor, Department of Medicine, Washington University Medical School, St. Louis, MO
  • 2003-1998: Assistant Professor, Department of Medicine, Washington University Medical School, St. Louis, MO
  • 1998-1996: Attending Physician, Department of Medicine, Cook County Hospital, Chicago, IL

University & Hospital Appointments & Committees

  • present-2019: Member, Siteman Cancer Center External Advisory Committee
  • present-2019: Member, Developmental Therapeutics Core Committee
  • present-2018: Member, Department of Surgery Ad Hoc Committee
  • present-2018: Member, Washington University IRB/HRPO Advisory Committee
  • present-2010: Member, Protocol Adherence Review Committee, Washington University School of Medicine
  • present-2010: Member, Committee on Admissions, Washington University School of Medicine
  • present-2010: Member, Barnes-Jewish Hospital Expansion Committee
  • present-2008: Member, Human Research Protection Organization
  • present-2005: Member, Protocol Review and Monitoring Committee
  • 2007-1999: Member, Cancer Committee, Barnes-Jewish Hospital
  • 2004-2001: Chairman, Education Subcommittee, Barnes-Jewish Hospital Cancer Committee, Siteman Cancer Center
  • 2004-2000: Member, Education Subcommittee, Barnes-Jewish Hospital Cancer Committee

Board Certification

  • 2008, 1997: American Board of Internal Medicine (Medical Oncology)
  • 1996: American Board of Internal Medicine (Hematology)
  • 1993: American Board of Internal Medicine

Honors & Awards

  • 2020: AACR Team Science Award
  • 2016: Anheuser Busch Endowed Chair in Medical Oncology
  • 2016: Alton Ochsner Award Related Smoking and Disease
  • 2001: ASCO Clinical Research Career Development Award for research titled “A Pilot Study of Celecoxib in Patients with Barrett’s Esophagus”
  • 1993: Alfred Pick Award for academic excellence during the Internal Medicine Residency at Michael Reese Hospital and Medical Center, Chicago, IL

International & National Committee Memberships

  • present-2019: Member, PierianDx Knowledgebase Expert Panel
  • present-2019: Member, The Cancer Genoma Atlas Lung Adenocarcimona Subgroup (TCGA LUAD) NIH/NCI
  • present-2018: Member, AACR Lung Cancer Research Fellowships Scientific Review Committee
  • present-2018: Member, ALCHEMIST Core Committee
  • present-2018: Member, K12 External Advisory Committee
  • present-2018: Member, PDX Steering Committee
  • present-2018: Co-Chair, SITC Lung Subcommittee
  • present-2018: Member, SITC Cancer Immunotherapy Guidelines (CIG) Committee
  • present-2014: Member, SITC/Medscape CME Project Steering Committee
  • present-2014: Member, ALCHEMIST Champions Team
  • present-2013: Member, National Comprehensive Cancer Network (NCCN) National Cancer Institute (NCI) Non-Small Cell Lung Cancer Panel
  • present-2012: Chair, IASLC CME Subcommittee
  • present-2010: Co-Chair, Lung Cancer Disease Working Group, The Cancer Genome Atlas Project
  • present-2009: Member, Subcommittee H, NCI
  • present-2009: Member, IASLC Pathology Committee
  • present-2008: Member, Cancer Center Review Panel, NCI
  • present-2008: Member, American College of Surgical Oncology (ACOSOG)
  • present-2008: Member, Education Committee, ASCO
  • present-2007: Member, NCCN Guidelines Committee, Non-Small Cell Lung Cancer
  • present-2002: Member, Clinical Oncology Advisory Board (COAB)
  • present-2001: Member, Respiratory Core Committee, Cancer and Leukemia Group B (CALGB)
  • present-2000: Member, Lung Committee, Hoosier Oncology Group (HOG)
  • present-2000: Member, Lung Steering Committee, Radiation Therapy Oncology Group (RTOG)
  • 2019: Member, Dr. Dubinett’s CLIN2-10784 Clinical Advisory Panel
  • 2014: Member, International Association for the Study of Lung Cancer Core Program Committee for the Treatment of Localized Disease NSCLC Track
  • 2010: Member (ad hoc), NCI Basic, Translational and Clinical Oncology Special Emphasis Panel
  • 2009: Member, Review Panel, American Recovery Reinvestment Act (ARRA)
  • 2008-2007: Member (ad hoc), NCI SPORE Review Panel
  • 2007-2005: Chair, Lung Committee (P2C-Mayo Consortium)
  • 2007-2000: Co-Chair, Lung Committee, Hoosier Oncology Group (HOG)
  • 2006-2004: Member, Lung Cancer Program Committee, American Society of Clinical Oncology
  • 2005-2002: Vice-Chair, Midwest Oncology Group (MOG)
  • 2003: Reviewer for Cancer Research UK (formerly ICRS and CRC) Phase I and II protocols
  • 2001-1998: Member, Oncology Training Program Committee, American Society of Clinical Oncology (ASCO)
  • 2000: Member, Quality Assurance Subcommittee, Radiation Therapy Oncology Group (RTOG)
  • 2009: Vice Chair, Medical Oncology Committee, American College of Surgical Oncology (ACOSOG)

Editorial Responsibilities

  • present-2010: Cancer Pharmacology, Lippincott, Williams & Wilkins
  • present-2010: Oncology Advisory Editor, Oncology Times
  • present-2009: Clinical Care Options InPractice Oncology
  • present-2008: Proceedings of the Annual Targeted Therapy Meeting Summary, International Association for the Study of Lung Cancer (ISLAC)
  • present-1999: ASCO Training Program Committee, Reading Syllabus on ASCO website
  • 2015: Washington Manual of Oncology, 3rd Edition, Lippincott, Williams & Wilkins Contemporary Oncology (bi-weekly newsletter/journal), Lippincott, Williams & Wilkins, Co-editor: Michael C. Perry
    Thoracic Oncology Matters (quarterly), Washington University School of Medicine
  • 2011-2008: ASCO Meeting Summaries
  • 2011-2006: ASCO Educational Book
  • 2009: DeVita, Hellman & Rosenberg’s “Cancer, Principles & Practice of Oncology Review” 2nd Edition, Lippincott Williams & Wilkins
  • 2009: Lung Cancer, Monograph, Lippincott, Williams & Wilkins
  • 2008: E-Update Series- Non-small Cell Lung Cancer, CMP Media
  • 2007: Washington Manual of Oncology, 2nd Edition, Lippincott, Williams & Wilkins
  • 2007: E-Update Series- Non-small Cell Lung Cancer, CMP Media
  • 2006: Locally Advanced Non-Small-Cell Lung Cancer: Cancer Management: a Multidisciplinary Approach, CMP United Business Media/Publishers of Oncology
  • 2005: DeVita, Hellman & Rosenberg’s “Cancer, Principles & Practice of Oncology Review”, Lippincott Williams & Wilkins
  • 2004: Locally Advanced Non-small Cell Lung Cancer: A Practical Management Guide, a COAB publication
  • 2002: Washington Manual of Oncology, Lippincott, Williams & Wilkins